Noile-Immune Biotech Inc.

TSE:4893 Stock Report

Market Cap: JP¥7.5b

Noile-Immune Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 4893?
Owner TypeNumber of SharesOwnership Percentage
Institutions-342,700-0.791%
Private Companies1,613,5203.73%
Public Companies10,396,82524%
General Public13,699,17031.6%
Individual Insiders17,934,95041.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 15 shareholders own 72.43% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.1%
Hiroko Ogihara
8,250,950JP¥1.4b-15.8%no data
18.8%
Takeda Pharmaceutical Company Limited
8,119,000JP¥1.4b0%no data
8.66%
Koji Tamada
3,750,000JP¥652.5m0%no data
5.26%
BINEX Co., Ltd.
2,277,825JP¥396.3m0%no data
4.62%
Kyoko Seto
2,000,000JP¥348.0m0%no data
3.23%
Satoshi Wada
1,399,000JP¥243.4m0%no data
3.12%
DCI Partners Co., Ltd.
1,349,000JP¥234.7m0%4.36%
2.68%
Hidenobu Ishizaki
1,160,000JP¥201.8m0%no data
2.31%
Yukimi Sakota
1,000,000JP¥174.0m0%no data
2.16%
BIGEN Co., Ltd.
933,270JP¥162.4m0%no data
1.57%
Apricot Co., Ltd.
680,250JP¥118.4m0%no data
0.81%
Hironari Hashioka
350,000JP¥60.9m0%no data
0.12%
Simplex Asset Management Co., Ltd.
51,700JP¥9.0m0%0.01%
0.058%
Tsutomu Tokashiki
25,000JP¥4.3m0%no data
0.038%
JGD Management Corp.
16,600JP¥2.9m0%0.01%